StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca tezspire (tezepelumab — direct product sales) — Emerging Markets product sales ($M) ($M)

Form 6-K / 20-F Product Sales Table

QuarterlyAnnual
Latest, Q2 2026
24
Period ended Jun 30, 2026
Change on a year earlier
+166.7%
9 in Q2 2025
History
15 quarters
Since Q4 2022
Sources
15
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTezspire (tezepelumab — direct product sales) — Emerging Markets product sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202624+166.7%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 202620+185.7%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 202516+300.0%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 20258+166.7%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 20259+200.0%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 20257+250.0%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 20244+300.0%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 20243–Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 20243–Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 20242–Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 20231–Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 20230–Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 20230–Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 20230–Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 20220–Form 6-K FY2022Q4 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Tezspire (tezepelumab — direct product sales) — Emerging Markets product sales ($M) ($M), quarterly Q4 2022–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med_tezspire_em

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.